Results for tag: "Belsomra"

Belsomra (suvorexant) is a prescription medication used to treat insomnia. It is a member of the class of drugs known as orexin receptor antagonists, which work by blocking the action of orexin, a neurotransmitter that helps regulate wakefulness. Belsomra is the only drug in its class approved by the U.S. Food and Drug Administration (FDA). It is available in tablet form and is taken once daily at bedtime. The Belsomra market is a subset of the larger Central Nervous System (CNS) drugs market. CNS drugs are used to treat a variety of conditions, including sleep disorders, anxiety, depression, and pain. Belsomra is the only orexin receptor antagonist approved by the FDA, and it is used to treat insomnia. Some companies in the Belsomra market include Merck & Co., Inc., Sunovion Pharmaceuticals, Inc., and Purdue Pharma L.P. Show Less Read more